Company Filing History:
Years Active: 2018-2020
Title: Innovations of Kyle M Whitten
Introduction
Kyle M Whitten is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for N-acylethanolamine hydrolyzing acid amidase (NAAA). With a total of 2 patents, his work is paving the way for advancements in therapeutic applications.
Latest Patents
Whitten's latest patents focus on N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their applications. The compounds he has developed are represented as Formula I, which includes tautomeric and stereoisomeric forms, as well as pharmaceutically acceptable salts. These compounds serve as inhibitors of NAAA, which is crucial for treating conditions mediated by this enzyme. The technology encompasses compounds, compositions, and methods aimed at inhibiting NAAA and addressing related health issues.
Career Highlights
Kyle M Whitten is affiliated with Northeastern University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on medical treatments and drug development.
Collaborations
Whitten collaborates with notable colleagues, including Michael Sotirios Malamas and Alexandros Makriyannis. Their combined expertise enhances the research efforts and contributes to the advancement of their projects.
Conclusion
Kyle M Whitten's contributions to the field of biochemistry through his patents and research at Northeastern University highlight his role as a significant innovator. His work on NAAA inhibitors is poised to make a meaningful impact in the medical field.